Trial · NCT00975195
Outcomes27
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 27
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Time to First Moderate or Severe On-treatment COPD Exacerbation | During randomised treatment, up to 488 days | Treated set | days | NUMBER |
| SECONDARY | Number of Moderate or Severe On-treatment COPD Exacerbations | During randomised treatment, up to 488 days | Treated Set | exacerbations per patient-year | MEAN |
| SECONDARY | Proportion of Patients With ≥1 Moderate or Severe On-treatment COPD Exacerbation | During randomised treatment, up to 488 days | Treated set | percentage of participants | NUMBER |
| SECONDARY | Time to First Severe On-treatment COPD Exacerbation | During randomised treatment, up to 488 days | Treated set | days | NUMBER |
| SECONDARY | Number of Severe On-treatment COPD Exacerbations | During randomised treatment, up to 488 days | Treated set | exacerbations per patient-year | MEAN |
| SECONDARY | Proportion of Patients With at Least One Severe On-treatment COPD Exacerbation. | During randomised treatment, up to 488 days | Treated set | percentage of participants | NUMBER |
| SECONDARY | Time to First On-treatment COPD Exacerbation | During randomised treatment, up to 488 days | Treated set | days | NUMBER |
| SECONDARY | Number of On-treatment COPD Exacerbations | During randomised treatment, up to 488 days | Treated set | exacerbations per patient-year | MEAN |
| SECONDARY | Proportion of Patients With at Least One On-treatment COPD Exacerbation | During randomised treatment, up to 488 days | Treated set | percentage of participants | NUMBER |
| SECONDARY | Severity of On-treatment COPD Exacerbations | During randomised treatment, up to 488 days | Treated set | percentage of participants | NUMBER |
| SECONDARY | Change in On-treatment Lung Function as Measured by Trough FEV1 | Baseline and week 6, 12, 18 and 52 visits | Treated set | Litres | LEAST_SQUARES_MEAN |
| SECONDARY | Changes in On-treatment Dyspnoea as Measured by the Modified Medical Research Council (MMRC) Dyspnoea Scale | Baseline and week 18 and 52 visits | Treated set | units on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Change in On-treatment Physical Health Status as Determined by Body Mass Index (BMI) | Baseline and week 18 and 52 visits | Treated set | kg/m2 | LEAST_SQUARES_MEAN |
| SECONDARY | Change in On-treatment Exercise Capacity Measured by Six-minute Walk Test (6-MWT) | Baseline and week 18 and 52 visits | Treated set | meters | LEAST_SQUARES_MEAN |
| SECONDARY | Change in On-treatment BODE Index | Baseline and week 18 and 52 visits | Treated set | units on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Change in On-treatment Cough and Expectoration as Measured by the CASA-Q: Cough Impact Domain | Baseline and week 12, 18 and 52 visits | Treated set who completed CASA-Q | units on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Change in On-treatment Cough and Expectoration as Measured by the CASA-Q: Cough Symptoms Domain | Baseline and week 12, 18 and 52 visits | Treated set who completed CASA-Q | units on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Change in On-treatment Cough and Expectoration as Measured by the CASA-Q: Sputum Impact Domain | Baseline and week 12, 18 and 52 visits | Treated set who completed CASA-Q | units on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Change in On-treatment Cough and Expectoration as Measured by the CASA-Q: Sputum Symptoms Domain | Baseline and week 12, 18 and 52 visits | Treated set who completed CASA-Q | units on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Change in On-treatment FEV1 as Measured by Home Based Spirometry | Baseline and week 6, 12, 18, 27, 36, 45 and 52 visits | Treated set | Litres | LEAST_SQUARES_MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00975195/outcomes